Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
30
pubmed:dateCreated
2003-7-21
pubmed:abstractText
Elevated synaptic levels of dopamine may induce striatal neurodegeneration in l-DOPA-unresponsive parkinsonism subtype of multiple system atrophy (MSA-P subtype), multiple system atrophy, and methamphetamine addiction. We examined the participation of dopamine and D1 dopamine receptors in the genesis of postsynaptic neurodegeneration. Chronic treatment of human SK-N-MC neuroblastoma cells with dopamine or H2O2 increased NO production and accelerated cytotoxicity, as indexed by enhanced nitrite levels and cell death. The antioxidant sodium metabisulfite or SCH 23390, a D1 dopamine receptor-selective antagonist, partially blocked dopamine effects but together ablated dopamine-mediated cytotoxicity, indicating the participation of both autoxidation and D1 receptor stimulation. Direct activation of D1 dopamine receptors with SKF R-38393 caused cytotoxicity, which was refractory to sodium metabisulfite. Dopamine and SKF R-38393 induced overexpression of the nitric-oxide synthase (NOS) isoforms neuronal NOS, inducible NOS (iNOS), and endothelial NOS in a protein kinase A-dependent manner. Functional studies showed that approximately 60% of total NOS activity was due to activation of iNOS. The NOS inhibitor N(G)-nitro-l-arginine methyl ester and genistein, wortmannin, or NF-kappaB SN50, inhibitors of protein tyrosine kinases phosphatidylinositol 3-kinase and NF-kappaB, respectively, reduced nitrite production by dopamine and SKF R-38393 but were less effective in attenuating H2O2-mediated effects. In rat striatal neurons, dopamine and SKF R-38393, but not H2O2, accelerated cell death through increased expression of neuronal NOS and iNOS but not endothelial NOS. These data demonstrate a novel pathway of dopamine-mediated postsynaptic oxidative stress and cell death through direct activation of NOS enzymes by D1 dopamine receptors and its associated signaling pathways.
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/2,3,4,5-Tetrahydro-7,8-dihydroxy-1-p..., http://linkedlifedata.com/resource/pubmed/chemical/Antioxidants, http://linkedlifedata.com/resource/pubmed/chemical/Benzazepines, http://linkedlifedata.com/resource/pubmed/chemical/Cyclic AMP-Dependent Protein..., http://linkedlifedata.com/resource/pubmed/chemical/Cyclic AMP-Dependent Protein Kinases, http://linkedlifedata.com/resource/pubmed/chemical/Enzyme Inhibitors, http://linkedlifedata.com/resource/pubmed/chemical/Free Radicals, http://linkedlifedata.com/resource/pubmed/chemical/Hydrogen Peroxide, http://linkedlifedata.com/resource/pubmed/chemical/NF-kappa B, http://linkedlifedata.com/resource/pubmed/chemical/NG-Nitroarginine Methyl Ester, http://linkedlifedata.com/resource/pubmed/chemical/NOS2 protein, human, http://linkedlifedata.com/resource/pubmed/chemical/Nitric Oxide Synthase, http://linkedlifedata.com/resource/pubmed/chemical/Nitric Oxide Synthase Type II, http://linkedlifedata.com/resource/pubmed/chemical/Nitrites, http://linkedlifedata.com/resource/pubmed/chemical/Nos2 protein, rat, http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Dopamine D1
pubmed:status
MEDLINE
pubmed:month
Jul
pubmed:issn
0021-9258
pubmed:author
pubmed:issnType
Print
pubmed:day
25
pubmed:volume
278
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
28089-100
pubmed:dateRevised
2011-10-27
pubmed:meshHeading
pubmed-meshheading:12738794-2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine, pubmed-meshheading:12738794-Animals, pubmed-meshheading:12738794-Antioxidants, pubmed-meshheading:12738794-Benzazepines, pubmed-meshheading:12738794-Cell Death, pubmed-meshheading:12738794-Cell Survival, pubmed-meshheading:12738794-Cells, Cultured, pubmed-meshheading:12738794-Cyclic AMP-Dependent Protein Kinase Type II, pubmed-meshheading:12738794-Cyclic AMP-Dependent Protein Kinases, pubmed-meshheading:12738794-Dopamine, pubmed-meshheading:12738794-Dose-Response Relationship, Drug, pubmed-meshheading:12738794-Endothelium, Vascular, pubmed-meshheading:12738794-Enzyme Activation, pubmed-meshheading:12738794-Enzyme Inhibitors, pubmed-meshheading:12738794-Free Radicals, pubmed-meshheading:12738794-Humans, pubmed-meshheading:12738794-Hydrogen Peroxide, pubmed-meshheading:12738794-Immunoblotting, pubmed-meshheading:12738794-Immunohistochemistry, pubmed-meshheading:12738794-NF-kappa B, pubmed-meshheading:12738794-NG-Nitroarginine Methyl Ester, pubmed-meshheading:12738794-Neuroblastoma, pubmed-meshheading:12738794-Neurons, pubmed-meshheading:12738794-Nitric Oxide Synthase, pubmed-meshheading:12738794-Nitric Oxide Synthase Type II, pubmed-meshheading:12738794-Nitrites, pubmed-meshheading:12738794-Oxidative Stress, pubmed-meshheading:12738794-Plasmids, pubmed-meshheading:12738794-Rats, pubmed-meshheading:12738794-Receptors, Dopamine D1, pubmed-meshheading:12738794-Signal Transduction, pubmed-meshheading:12738794-Time Factors, pubmed-meshheading:12738794-Transfection, pubmed-meshheading:12738794-Tumor Cells, Cultured
pubmed:year
2003
pubmed:articleTitle
Chronic stimulation of D1 dopamine receptors in human SK-N-MC neuroblastoma cells induces nitric-oxide synthase activation and cytotoxicity.
pubmed:affiliation
Department of Pediatrics, Georgetown University, Washington, DC 20007, USA.
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, P.H.S., Research Support, Non-U.S. Gov't